AbCellera Biologics reported total assets of $1307.58M and total liabilities of $411.56M for the quarter ended Jun 2026, down 6.7% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 8.51M | 9.83M | 11.21M | 13.22M | 15.74M | 18.48M | ||||||||||||||||||||
| Loans - NetNet Loans | 5.40M | |||||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 517.69M | 722.98M | 786.05M | 1,022.27M | 868.21M | 886.49M | 796.50M | 795.69M | 785.84M | 133.32M | 123.57M | 148.31M | 126.64M | 156.32M | 159.27M | 92.44M | 83.16M | 128.51M | 77.06M | 120.06M | ||||||
| Receivables - NetNet Receivables | 43.63M | 160.58M | 334.40M | 52.80M | 105.96M | 38.59M | 20.00M | 45.68M | 37.45M | 30.59M | 34.42M | 36.14M | 31.37M | 33.62M | 63.61M | 70.00M | 71.25M | 58.29M | 39.16M | 38.42M | ||||||
| Receivables - OtherOther Receivables | ||||||||||||||||||||||||||
| Receivables | 43.63M | 160.58M | 334.40M | 52.80M | 105.96M | 38.59M | 20.00M | 45.68M | 37.45M | 30.59M | 34.42M | 36.14M | 31.37M | 33.62M | 63.61M | 70.00M | 71.25M | 58.29M | 39.16M | 38.42M | ||||||
| Prepaid Assets | 5.29M | 9.06M | ||||||||||||||||||||||||
| Current Assets | 803.75M | 929.80M | 1,174.38M | 1,143.95M | 1,045.67M | 1,025.49M | 940.65M | 930.74M | 919.52M | 871.99M | 813.95M | 771.55M | 742.88M | 751.37M | 764.98M | 742.14M | 695.14M | 728.23M | 664.60M | 679.23M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Construction in Progress | 10.50M | 13.20M | 13.70M | 15.20M | 13.00M | 108.40M | 117.60M | 126.20M | 139.10M | 145.30M | 3.50M | |||||||||||||||
| Property, Plant & Equipment (Net) | 91.58M | 111.62M | 122.05M | 149.18M | 200.60M | 217.25M | 233.19M | 259.64M | 277.21M | 287.70M | 306.08M | 318.88M | 331.26M | 340.43M | 347.10M | 424.02M | 427.36M | 428.00M | 422.81M | 416.68M | ||||||
| Long-Term Investments | 47.51M | 50.31M | 58.88M | 65.82M | 66.72M | 72.52M | 57.58M | 58.79M | 62.89M | 65.94M | 71.59M | 76.06M | 84.08M | 82.30M | 81.57M | 90.37M | 93.30M | 62.58M | 65.31M | 65.23M | ||||||
| Goodwill | 49.46M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | ||||||
| Intangibles | 148.82M | 148.39M | 145.78M | 143.18M | 142.55M | 131.50M | 128.84M | 126.75M | 124.08M | 120.42M | 118.74M | 85.66M | 52.58M | 42.11M | 41.19M | 40.26M | 39.32M | 38.38M | 37.46M | 36.53M | ||||||
| Goodwill & Intangibles | 198.28M | 196.20M | 193.59M | 190.99M | 190.35M | 179.31M | 176.65M | 174.55M | 171.88M | 168.23M | 166.54M | 133.47M | 100.38M | 89.92M | 89.00M | 88.07M | 87.13M | 86.19M | 85.27M | 84.34M | ||||||
| Other Non-Current Assets | 31.62M | 30.64M | 43.39M | 43.84M | 49.07M | 46.33M | 89.84M | 113.45M | 80.69M | 94.24M | 104.93M | 112.51M | 134.22M | 96.54M | 61.56M | 57.45M | 53.07M | 51.95M | 69.14M | 62.10M | ||||||
| Non-Current Assets | 368.99M | 388.77M | 417.91M | 449.83M | 506.74M | 515.42M | 557.27M | 606.43M | 592.67M | 616.11M | 649.15M | 640.93M | 649.95M | 609.18M | 579.23M | 659.92M | 660.85M | 628.72M | 642.52M | 628.35M | ||||||
| Assets | 1,172.73M | 1,318.57M | 1,592.29M | 1,593.78M | 1,552.41M | 1,540.91M | 1,497.92M | 1,537.17M | 1,512.19M | 1,488.09M | 1,463.10M | 1,412.48M | 1,392.83M | 1,360.55M | 1,344.21M | 1,402.06M | 1,355.99M | 1,356.95M | 1,307.11M | 1,307.58M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 24.07M | 32.02M | 25.72M | 24.39M | 25.87M | 52.50M | 31.81M | 52.40M | 35.71M | 49.58M | 42.89M | 43.95M | 53.77M | 55.00M | 47.84M | 50.07M | 53.12M | 50.78M | 39.55M | 32.48M | ||||||
| Payables | 24.07M | 32.02M | 25.72M | 24.39M | 25.87M | 52.50M | 31.81M | 52.40M | 35.71M | 49.58M | 42.89M | 43.95M | 53.77M | 55.00M | 47.84M | 50.07M | 53.12M | 50.78M | 39.55M | 32.48M | ||||||
| Other Accumulated Expenses | 0.59M | 22.51M | 45.36M | 50.55M | 17.82M | 19.35M | 3.09M | 3.09M | 3.09M | |||||||||||||||||
| Current Taxes | 6.59M | 35.68M | 105.65M | 107.32M | 23.02M | |||||||||||||||||||||
| Current Deferred Revenue | 6.17M | 7.54M | 9.19M | 4.62M | 6.82M | 21.61M | 11.81M | 8.54M | 17.51M | 18.96M | 10.56M | 6.40M | 5.58M | 13.52M | 18.79M | 16.95M | 15.69M | 13.53M | 7.74M | 20.70M | ||||||
| Total Current Liabilities | 49.55M | 120.68M | 213.42M | 221.14M | 106.05M | 118.32M | 89.59M | 118.91M | 110.24M | 119.01M | 104.88M | 70.38M | 79.57M | 76.61M | 75.40M | 67.02M | 68.80M | 64.31M | 47.29M | 53.19M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 59.68M | 27.41M | 64.15M | 64.80M | 62.20M | 19.52M | 25.42M | 27.72M | 16.38M | 95.92M | 8.57M | 124.19M | 142.05M | 149.89M | 157.19M | 167.53M | 169.12M | 174.45M | 176.10M | 178.25M | ||||||
| Operating Leases | 27.26M | 36.41M | 36.36M | 32.76M | 71.59M | 76.67M | 77.27M | 78.08M | 75.19M | 71.22M | 68.08M | 66.45M | 66.27M | 60.74M | 63.21M | 137.18M | 137.05M | 137.40M | 134.31M | 129.95M | ||||||
| Non-Current Deferred Tax Liability | 36.20M | 37.40M | 36.80M | 34.62M | 34.14M | 33.18M | 33.43M | 33.18M | 33.18M | 30.61M | 30.27M | 21.74M | 12.78M | 10.05M | 10.05M | 10.05M | 9.74M | 9.12M | ||||||||
| Other Non-Current Liabilities | 44.95M | 35.89M | 30.62M | 24.63M | 25.39M | 16.05M | 15.73M | 5.77M | 5.31M | 5.91M | 5.74M | 6.35M | 4.44M | 7.17M | 1.62M | 1.56M | 1.39M | 10.38M | 11.32M | 9.71M | ||||||
| Total Non-Current Liabilities | 169.79M | 172.16M | 171.36M | 159.79M | 196.19M | 189.31M | 199.83M | 223.43M | 219.18M | 216.76M | 228.30M | 231.13M | 235.17M | 227.86M | 245.83M | 327.96M | 323.15M | 325.74M | 321.74M | 358.37M | ||||||
| Total Liabilities | 219.34M | 292.84M | 384.78M | 380.93M | 302.24M | 307.63M | 289.42M | 342.34M | 329.42M | 335.78M | 333.18M | 301.51M | 314.73M | 304.47M | 321.23M | 394.99M | 391.95M | 390.05M | 369.03M | 411.56M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Common Equity | 953.40M | 1,025.73M | 1,207.51M | 1,212.86M | 1,250.17M | 1,233.28M | 1,208.50M | 1,194.83M | 1,182.78M | 1,152.32M | 1,129.91M | 1,110.97M | 1,078.09M | 1,056.08M | 1,022.98M | 1,007.08M | 964.04M | 966.90M | 938.08M | 896.02M | ||||||
| Liabilities and Shareholders Equity | 1,172.73M | 1,318.57M | 1,592.29M | 1,593.78M | 1,552.41M | 1,540.91M | 1,497.92M | 1,537.17M | 1,512.19M | 1,488.09M | 1,463.10M | 1,412.48M | 1,392.83M | 1,360.55M | 1,344.21M | 1,402.06M | 1,355.99M | 1,356.95M | 1,307.11M | 1,307.58M | ||||||
| Retained Earnings | 207.72M | 267.67M | 436.24M | 429.45M | 456.08M | 426.19M | 386.07M | 355.55M | 326.94M | 279.79M | 239.18M | 202.25M | 151.14M | 116.93M | 71.31M | 36.58M | -20.54M | -29.48M | -72.65M | -128.07M |
Pull AbCellera Biologics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ABCL&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ABCL", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ABCL&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();